Rube Goldberg-the cartoonist who devised complex machines for simple tasks-would have smiled at one of leptin’s mechanisms for curbing insulin release. As Hinoi et al. show, the fat-derived hormone enlists the sympathetic nervous system to prevent bone-making cells from releasing a molecule that prods the pancreas to discharge insulin.
The study appeared online December 22, 2008 (http://www.jcb.org) and in the December 29, 2008 print issue of The Journal of Cell Biology (JCB).
In the fight against obesity and diabetes, leptin is one of the good guys. Mice lacking the hormone become corpulent, and their sky-high insulin levels eventually lead to diabetes. Leptin can curtail insulin release directly. But there’s also a back-door route that researchers are still trying to piece together. Scientists knew that leptin nudges osteoblasts, cells known for building bone but that also manufacture osteocalcin, a protein that stimulates insulin release. Hinoi et al. tested whether leptin acts on the pancreas through osteocalcin.
Leptin channels many of its effects through the nervous system. The team thus tested whether the hormone relied on the sympathetic nervous system, the branch that pumps out adrenaline during emergencies but at other times emits a hormonal trickle to maintain a low level of stimulation. This baseline activity was lower in mice lacking the leptin receptor, indicating a connection between leptin and the sympathetic nervous system. When that connection was broken by deleting the adrenaline receptor from mice osteoblasts, insulin levels shot up.
The researchers then dosed mice with a sympathetic stimulator. Rodents lacking leptin or the adrenaline receptor on their osteoblasts turned out normal amounts of osteocalcin, but much of it was in an inert form. That result suggests leptin affects insulin release by indirectly inactivating osteocalcin. The work boosts researchers’ hopes of using osteocalcin to treat diabetes-a possibility some drug companies have already started to investigate.
Notes:
About The Journal of Cell Biology
Founded in 1955, The Journal of Cell Biology/ (JCB) is published by the Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists. JCB content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit http://www.jcb.org.
Hinoi, E., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200809113
Source:
Rita Sullivan
Rockefeller University
Similar Posts:
- Drug That Counteracts The Effects Of Leptin May Benefit Cardiac Stent Patients With Diabetes
- Reduction In Antibody Gene Rearrangement In B Cells Related To Type 1 Diabetes, Lupus
- New Gene Found To Be Associated With Widely-used Marker Of Blood Glucose Concentration
- A New Light On Tumor Immunotherapy For Gastric Cancer
- Extra-Virgin Olive Oil Has Anti-Cancer Components
The naturally high levels of leptin in diabetic patients may reduce the effectiveness of drug-eluting stents used to treat heart blockages, but using a chemical that differs from the one commonly used to coat stents could counteract this effect. The work by researchers at Columbia University Medical Center could potentially improve outcomes in diabetics who get stents, they say. Though drug-eluti
More drafts usually mean a better product and so it also seems to go with the human immune system. As B cells develop, genes rearrange to allow antibodies to recognize different foreign invaders or pathogens. But sometimes antibodies are created that recognize and attack the body’s own cells. These self-reactive antibodies, like early drafts of a manuscript, must be edited into versions that won’
Scientists have found that genetic variation at the hexokinase-1 gene is linked to variation in the blood concentration of glycated hemoglobin, an index of long-term blood glucose concentration widely used in the follow-up of diabetes patients. The study, conducted by researchers from the Brigham and Women’s Hospital in Boston, USA, is published December 19 in the open-access journal PLoS Genetic
Dendritic cells (DCs) are professional antigen presenting cells (APCs) that both initiate and modulate the immune response. DCs are cells in the pathway of antigen capture and presentation to T cells, with the unique ability to directly prime naïve CD4+ and CD8+ T cells. Gastric cancer is one of the most common cancers. Although gastric cancer therapy has made great progress, it is still difficul
Good quality extra-virgin olive oil contains health-relevant chemicals, ‘phytochemicals’, that can trigger cancer cell death. New research published in the open access journal BMC Cancer sheds more light on the suspected association between olive oil-rich Mediterranean diets and reductions in breast cancer risk. Javier Menendez from the Catalan Institute of Oncology and Antonio Segura-Carretero f